Detalhe da pesquisa
1.
Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long-term endpoint: The non-Gaussian case.
Pharm Stat
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38837876
2.
Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint.
Pharm Stat
; 21(1): 209-219, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34505395
3.
Bayesian biomarker-driven outcome-adaptive randomization with an imperfect biomarker assay.
Clin Trials
; 18(2): 137-146, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231131
4.
Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference-test.
Biometrics
; 73(2): 646-655, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27598904
5.
Development of a diagnostic test based on multiple continuous biomarkers with an imperfect reference test.
Stat Med
; 35(4): 595-608, 2016 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26388206
6.
Trial Design for Cancer Immunotherapy: A Methodological Toolkit.
Cancers (Basel)
; 15(18)2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760636
7.
Transferring cut-off values between assays for cerebrospinal fluid Alzheimer's disease biomarkers.
J Alzheimers Dis
; 49(1): 187-199, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26484919
8.
Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.
J Alzheimers Dis
; 49(4): 927-43, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26519433